131

(HLiv-HCC180Bch-01) Liver cancer tissue array with biochemical indicators (AFP, HBV, HCV RNA, Creatinine, Urea nitrogen, CEA), 49 cases. 41 cases have tumor and matched normal adjacent tissue (NAT.

10 cases of hepatocellular carcinoma

10 cases,tumor and matched NAT.

10 cases,tumor and NAT.

15 cases of hepatocellular carcinoma

15 cases,tumor and NAT.

29 cases,tumor and NAT.

30 cases of pancreatic carcinoma and matched NAT.

30 cases of  breast cancer (infiltrating ductal carcinoma)��� tumor 1  core/case  Clinical stage 1,2,3,4 (Version 6.0).

30 cases,tumor and matched adjacent tissue.

30 cases,tumor and NAT.

30 cases,tumor, colon

30 cases,tumor, Esophagus

30 cases,tumor, lung

35 cases,tumor and NAT.

35 types of normal human tissue array, 90 cases/96 cores

41 cases of pancrease tissue,with normal tisse, carcinoma and NAT.

6 types of digestive system tumor tissue array, 10 cases / type. 6 types of normal tissue, 2-5 cases / type

60 cases,tumor only

Adamantinoma and hamartoma tissue array, 40 cases/80 cores

Adenoid cystic carcinoma tissue array, 40 cases/80 cores

Adipose tissue disease spectrum (adipose tumor progression) tissue array, 104 cases/208 cores

Adjacent normal kidney tissue and cancer tissue array, including TNM, clinical stage and pathology grade, 20 cases/54 cores, replacing BN07011

Adrenal gland cancer test tissue array, with normal tissue, 2 serial sections, 6 cases/26 cores

Adrenal gland disease spectrum (adrenal cancer progression) tissue array, 100 cases/200 cores

Adrenal tumor tissue array, 80 cases/80 cores

Advanced breast cancer and normal tissue array, with stage, TNM and pathology grade info, 80 cases/80 cores

Advanced colon cancer tissue array, with stage and grade info, 80 cases/80 cores

Advanced colon carcinoma tissue array, 45 cases

Advanced colon tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases/192 cores

Advanced kidney cancer tissue array, with stage and grade info, 80 cases/80 cores

Advanced lung cancer and normal tissue array, with stage TNM and grade info, 80 cases/80 cores

Advanced stage pancreas cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases/192 cores, replacing PA1921a

Advanced stage pancreas cancer tissue array, including TNM, clinical stage, pathology grade and IHC marker (CK) results, 96 cases/192 cores, replacing PA1921

Advanced stomach adenocarcinoma tissue array, 75 cases. Tumor and matched NAT.

Age grouped female skin tissue array, 12 cases/24 cores, replacing SK244

Anal canal cancer with rectrum tissue array, including TNM, clinical stage and pathology grade, 24 cases/ 44 cores

Anaplastic large cell lymphoma tissue array, 24 cases/ 24 cores

Antibody cross-reactivity testing tissue array, 33 cases/34 cores

Appendix cancer test tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 6 cases/24 cores

Astrocytoma and glioblastoma tissue array with unmatched normal adjacent tissues, 48 cases/48 cores

Bile ducts cancer, 91 cases.31 cases have tumor and matched NAT.

Bladder cancer (stage III-IV) tissue array, including TNM, clinical stage and pathology grade, 60 cases/60 cores

Bladder cancer and normal tissue array with TNM and grade data, 40 cases/80 cores

Bladder cancer high density tissue array with normal tissue as control, including TNM and clinical stage, 208 cases/208 cores, replacing BL2081a

Bladder cancer mid-density tissue array, 75 cases/150 cores

Bladder cancer test tissue array, with normal bladder control tissues, including TNM, clinical stage and pathology grade, 6 cases/24 cores, replacing T121

Bladder cancer test tissue array, with normal bladder tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/24 cores

Bladder cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replaced by T124

Bladder cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases/100 cores

Bladder cancer tissue array with matched adjacent normal bladder tissue, including TNM and pathology grade, 24 cases/63 cores

Bladder cancer tissue array with matched cancer adjacent bladder tissue, including TNM, 12 cases/24 cores, replacing BL244

Bladder cancer tissue array with matched cancer adjacent tissue, including TNM and pathology grade, 10 cases/24 cores, replacing BL241

Bladder cancer tissue array with normal bladder tissue as control, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing T124a

Bladder cancer tissue array with normal bladder tissue, including pathology grade, TNM and clinical stage, 48 cases/48 cores, replaced by BL481c

Bladder cancer tissue array with normal tissue, including TNM, clinical stage and pathology grade, 80 cases/80 cores, replacing BL802a

Bladder cancer tissue array with normal tissues from autopsy, 12 cases/24 cores with stage and grade data

Bladder cancer tissue array with normal tissues, 24 cases/72 cores

Bladder cancer tissue array, 12 cases/24 cores

Bladder cancer tissue array, 33 cases/66 cores

Bladder cancer tissue array, 59 cases. 46 cases have tumor and matched normal adjacent tissue (NAT.

Bladder cancer tissue array, including TNM and clinical stage, 63 cases/63 cores, replacing BC12011c

Bladder cancer tissue array, including TNM and pathology grade, 48 cases/48 cores

Bladder cancer tissue array, including TNM, 63 cases/63 cores, replaced by BC12011d

Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 208 cases/ 208 cores, replacing BL2082

Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases/24 cores

Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores

Bladder cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases/48 cores

Bladder cancer with normal bladder tissue array, including TNM and clinical stage, 48 cases/48 cores, replacing BL481b

bladder carcinoma (33 cases) and NAT.

Bladder carcinoma tissue microarray (56 cases) and normal adjacent tissue. With survival data. Replaces HBla-Uro105Sur-01

Bladder disease spectrum (urocystic cancer progression) tissue array, 80 cases/80 cores

Bladder tumor tissue array(15 cases), renal clear cell carcinoma (16 cases).

Blastoma tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases/80 cores, replacing MC809

Blood vessel disease spectrum (blood vessel cancer progression) tissue array, 80 cases/80 cores

Bone and bone marrow tissue with osteosarcoma tissue array, including TNM and clinical stage, 12 cases/24 cores, replacing BO244e

Bone and cartilage cancer tissue array with unmatched normal adjacent tissues, 12 cases/24 cores

Bone and cartilage disease spectrum (bone and cartilage cancer progression) tissue array, 80 cases/80 cores

Bone and cartilage malignant tumor tissue array, including TNM and clinical stage, 6 cases/24 cores, replacing T264

Bone and cartilage tumor tissue array with bone tissue, including TNM and clinical stage, 48 cores/48 cases, replacing BO481

Bone and cartilage tumor tissue array, with normal tissue, including TNM, 6 cases/24 cores

Bone disease spectrum (bone tumor progression) tissue array, 104 cases/208 cores

Bone giant cell tumor tissue array, 30 cases/60 cores

Bone marrow tissue array, 12 cases/24 cores, replacing BM241

Bone marrow tissue array, 33 cases/60 cores, replacing BN29011

Bone marrow tumor and normal tissue array, including TNM, 6 cases/24 cores, replacing T293

Bone tumor and adjacent normal tissue array, 24 cases/48 cores, replacing BM483b

Bone tumor and adjacent normal tissue array, including TNM and clinical stage, 24 cases/48 cores, replaced by BM483c

Bone tumor and cartilage tumor tissue array, with normal bone and cartilage tissues, including TNM and clinical stage, 6 cases/24 cores, replacing T261a

Bone tumor test tissue array with normal tissue as control, including TNM, clinical stage, 12 cases/ 24 cores, replacing T262

Brain astrocytoma and meningioma tissue array, 120 cases/120 cores

Brain cancer and adjacent normal tissue array, including pathology grade, 80 cases/80 cores���replacing GL803b

Brain cancer and normal tissue array, including pathology grade, 100 cases/100 cores, replacing GL1001

Brain cancer tissue array, including pathology grade, 63 cases/ 63 cores, replacing BS17015

Brain disease spectrum (brain cancer progression) tissue array, with stage, TNM and grade info, 79 cases/80 cores

Brain glioblastoma tissue array with normal tissue, including pathology grade, 40 cases/ 80 cores, replaced by GL805b

Brain glioblastoma tissue array, including pathology grade, 40 cases/80 cores, replaced by BS17016c

Brain glioblastoma tissue array, including pathology grade, 40 cases/80 cores, replacing BS17016b

Brain glioblastoma with normal brain tissue array, including pathology grade, 40 cases/80 cores, replacing GL806e